Re-appointment of Dr. (Ms.) Vasudha Kamat and Mr. Abhijit Gore as an Independent Directors of the Company for second term of five years, subject to the approval of the shareholders
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies' Board, at its meeting on 22nd May 2025, approved the re-appointment of Dr. (Ms.) Vasudha Kamat as an Independent Director for a second 5-year term from 24th September 2025 to 23rd September 2030, and Mr. Abhijit Gore as an Independent Director for a second 5-year term from 3rd October 2025 to 2nd October 2030. Both re-appointments are subject to shareholder approval at the upcoming Annual General Meeting. The Board also re-appointed M/s A. Y. Sathe & Co as Secretarial Auditor for a 5-year term (1st April 2025 to 31st March 2030) and appointed M/s. Suresh Surana & Associates LLP as Internal Auditors for FY 2025-2026. Both independent directors are confirmed as not debarred by SEBI and not related to any existing Board member.
This is a routine governance announcement with no material impact on the stock. It signals board continuity and stable oversight, with no changes in management or negative governance flags.